Literature DB >> 10805606

Precipitated and spontaneous withdrawal in rats tolerant to anandamide.

B Costa1, G Giagnoni, M Colleoni.   

Abstract

RATIONALE: There is evidence that cannabinoids cause tolerance and physical dependence in humans and animals.
OBJECTIVES: The aim of this work was to study whether the endogenous ligand for the cannabinoid receptor, arachidonylethanolamide (anandamide), induced behavioral tolerance and physical dependence in rats.
METHODS: Rats were injected with anandamide (20 mg/kg i.p.) daily for 2 weeks. To assess tolerance, on days 1, 8 and 15 of treatment rats were observed and behavior was tested. Two common methods were employed to assess physical dependence: interruption of anandamide dosing and vehicle substitution or administration of the cannabinoid CB1 receptor antagonist SR141716A (3 mg/kg i.p.).
RESULTS: Full or partial tolerance developed to the classical behavioral effects elicited by the cannabinoids: hypothermia, catalepsy, hypomotility, decrease in stereotypic activity (rearing and grooming) and hindlimb splaying. No tolerance to anandamide was observed for reduced defecation. An abstinence syndrome appeared after abrupt cessation of cannabinoid intake and after withdrawal precipitated by SR141716A; the withdrawal signs were scratching, licking and biting, eating of feces, ptosis, arched back, wet dog shakes, head shakes, myoclonic spasms, writhing, forepaw fluttering, teeth chattering and piloerection.
CONCLUSIONS: These findings indicate that the endogenous cannabinoid ligand, administered exogenously, induces both tolerance and physical dependence in rats.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10805606     DOI: 10.1007/s002139900360

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  12 in total

1.  Evaluation of fatty acid amides in the carrageenan-induced paw edema model.

Authors:  Laura E Wise; Roberta Cannavacciulo; Benjamin F Cravatt; Billy F Martin; Aron H Lichtman
Journal:  Neuropharmacology       Date:  2007-06-22       Impact factor: 5.250

Review 2.  Endocannabinoid influence in drug reinforcement, dependence and addiction-related behaviors.

Authors:  Antonia Serrano; Loren H Parsons
Journal:  Pharmacol Ther       Date:  2011-07-18       Impact factor: 12.310

3.  Parent and peer influences on emerging adult substance use disorder: A genetically informed study.

Authors:  Kaitlin Bountress; Laurie Chassin; Kathryn Lemery-Chalfant
Journal:  Dev Psychopathol       Date:  2016-01-12

Review 4.  Drug addiction.

Authors:  Zuzana Justinova; Leigh V Panlilio; Steven R Goldberg
Journal:  Curr Top Behav Neurosci       Date:  2009

5.  The endogenous cannabinoid anandamide and its synthetic analog R(+)-methanandamide are intravenously self-administered by squirrel monkeys.

Authors:  Zuzana Justinova; Marcello Solinas; Gianluigi Tanda; Godfrey H Redhi; Steven R Goldberg
Journal:  J Neurosci       Date:  2005-06-08       Impact factor: 6.167

Review 6.  Marijuana dependence: not just smoke and mirrors.

Authors:  Divya Ramesh; Joel E Schlosburg; Jason M Wiebelhaus; Aron H Lichtman
Journal:  ILAR J       Date:  2011

Review 7.  Cannabis reinforcement and dependence: role of the cannabinoid CB1 receptor.

Authors:  Ziva D Cooper; Margaret Haney
Journal:  Addict Biol       Date:  2008-02-14       Impact factor: 4.280

Review 8.  Inhibition of FAAH and activation of PPAR: new approaches to the treatment of cognitive dysfunction and drug addiction.

Authors:  Leigh V Panlilio; Zuzana Justinova; Steven R Goldberg
Journal:  Pharmacol Ther       Date:  2013-01-16       Impact factor: 12.310

9.  Is cannabis a risk factor for suicide attempts in men and women with psychotic illness?

Authors:  A Waterreus; P Di Prinzio; J C Badcock; M Martin-Iverson; A Jablensky; V A Morgan
Journal:  Psychopharmacology (Berl)       Date:  2018-05-16       Impact factor: 4.530

Review 10.  Cannabinoids: reward, dependence, and underlying neurochemical mechanisms--a review of recent preclinical data.

Authors:  Gianluigi Tanda; Steven R Goldberg
Journal:  Psychopharmacology (Berl)       Date:  2003-06-24       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.